Immunotherapy for metastatic renal cell carcinoma: A brief history, current trends, and future directions.

Rambhia, Ami; Patel, Rutul D; Okhawere, Kennedy E; Korn, Talia G; Badani, Ketan K

Rambhia, Ami; Patel, Rutul D; Okhawere, Kennedy E; Korn, Talia G; Badani, Ketan K.

Afiliación

Rambhia A; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY.
Patel RD; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY.
Okhawere KE; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY.
Korn TG; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY.
Badani KK; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: ketan.badani@mountsinai.org.

Urol Oncol ; 39(10): 664-677, 2021 10.

Article en En | MEDLINE | ID: mdl-34312081

Asunto(s)

Carcinoma de Células Renales/tratamiento farmacológico; Inhibidores de Puntos de Control Inmunológico/uso terapéutico; Inmunoterapia/métodos; Neoplasias Renales/tratamiento farmacológico; Carcinoma de Células Renales/patología; Femenino; Humanos; Inhibidores de Puntos de Control Inmunológico/farmacología; Neoplasias Renales/patología; Masculino; Metástasis de la Neoplasia

Palabras clave

Immune checkpoint inhibitors; Metastatic renal cell carcinoma, Immunotherapy; National cancer database; National comprehensive cancer network guidelines

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Inhibidores de Puntos de Control Inmunológico / Inmunoterapia / Neoplasias Renales Límite: Female / Humans / Male Idioma: En Revista: Urol Oncol Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google